A stimulus-responsive magnetic nanoparticle drug carrier: Magnetite encapsulated by chitosan-grafted-copolymer
Source abstract
Abstract
We describe a magnetic nanoparticle drug carrier for controlled drug release that responds to the change in external temperature or pH, with characteristics of longer circulation time and reduced side effects. The novel nanocarrier is characterized by a functionalized magnetite (Fe(3)O(4)) core that is conjugated with drug via acid-labile hydrazone-bond and encapsulated by the thermosensitive smart polymer, chitosan-g-poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide) [chitosan-g-poly(NIPAAm-co-DMAAm)]. The chitosan-g-poly(NIPAAm-co-DMAAm) smart polymer exhibits a lower critical solution temperature (LCST) of approximately 38 degrees C, signifying phase transition behavior of the smart polymer and enabling its use for triggering on-off mechanisms. The drug release response was appreciably low at a temperature less than the LCST as compared with a temperature above the LCST. In each case, there was an initial rapid drug release, followed by a controlled released in the second stage, especially in a mild acidic buffer solution of pH 5.3. We believe that the drug release occurs via a collapse of the encapsulated thermosensitive polymer and cleavage of the acid-labile hydrazone linkage.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Hydrogels: synthesis, properties, applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties10.1016/S0168-3659(01)00281-4 ↗
2. Evaluation of a new controlled-drug delivery concept based on the use of thermoresponsive polymers10.1016/S0378-5173(02)00198-9 ↗
3. Design strategies to improve soluble macromolecular delivery constructs10.1016/S0169-409X(02)00229-6 ↗
4. Nanoparticle and targeted systems for cancer therapy10.1016/j.addr.2004.02.014 ↗
5. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(d,l-lactide-co-glycolide) with varying compositions10.1016/j.biomaterials.2005.01.030 ↗
6. Biodegradable thermo-sensitive nanoparticles from poly(l-lactic acid)/poly(ethylene glycol) alternating multi-block copolymer for potential anti-cancer drug carrier10.1016/j.ejps.2005.08.012 ↗
7. Medical application of functionalized magnetic nanoparticles10.1263/jbb.100.1 ↗
8. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications10.1016/j.biomaterials.2004.10.012 ↗
9. Targeted nanoparticles for detecting and treating cancer10.1002/ddr.20069 ↗
10. Magnetic fluid hyperthermia (MFH): cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles10.1016/S0304-8853(99)00088-8 ↗
11. Superparamagnetic gel as a novel material for electromagnetically induced hyperthermia10.1016/S0304-8853(00)01237-3 ↗
12. Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia10.1016/S0304-8853(00)01239-7 ↗
13. Targeting liver tumors with hyperthermia: ferromagnetic embolization in a rabbit liver tumor model10.1002/jso.1118 ↗
14. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature
15. Thermosensitive magnetic polymer particles as contactless controllable drug carriers10.1016/j.jmmm.2005.05.043 ↗
16. Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments10.1021/bc050050z ↗
17. Iron oxide nanoparticles for sustained delivery of anticancer agents10.1021/mp0500014 ↗
18. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells10.1021/la0503451 ↗
19. Effects of coil dimensions and field polarization on RF heating inside a head phantom10.1016/j.mri.2004.11.007 ↗
20. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging10.1002/nbm.1011 ↗
21. Dendrimer-functionalized iron oxide nanoparticles for specific targeting and imaging of cancer cells10.1002/adfm.200601139 ↗
22. Preparation of biocompatible magnetite nanocrystals for in vivo magnetic resonance detection of cancer10.1002/adma.200600385 ↗
23. A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents10.1021/ja049195r ↗
24. Aqueous dispersion of monodisperse magnetic iron oxide nanocrystals through phase transfer10.1088/0957-4484/17/17/033 ↗
25. Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture10.1023/B:JMSM.0000021126.32934.20 ↗
26. Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxity studies
27. Stimuli responsive polymers for biomedical applications10.1039/B406727D ↗
28. Synthetic polymers as drugs and therapeutics10.1039/B410799N ↗
29. Thermally responsive core–shell nanoparticles self-assembled from cholesteryl end-capped and grafted polyacrylamides: drug incorporation and in vitro release10.1016/j.biomaterials.2003.10.095 ↗
30. Thermosensitive polymer-modified liposomes10.1016/S0169-409X(01)00204-6 ↗
31. Simultaneous monitoring of temperature and t1: methods and preliminary results of application to drug delivery using thermosensitive liposomes10.1002/mrm.20635 ↗
32. Synthesis and characterization of dextran grafted with poly(N-isopropylacrylamide-co-N,N-dimethyl-acrylamide)10.1002/(SICI)1521-3935(20000301)201:5<613::AID-MACP613>3.0.CO;2-I ↗
33. Formulation and characterization of chitosan-based hydrogel films having both temperature and pH sensitivity10.1007/s10856-007-3030-9 ↗
34. New synthetic route for dextran graft copolymers containing thermo-responsive polymers10.1295/polymj.33.108 ↗
35. Modulatory factors on temperature-synchronized degradation of dextran grafted with thermoresponsive polymers and their hydrogels10.1021/bm015527y ↗
36. Magnetic drug-targeting carrier encapsulated by thermosensitive smart polymer: core–shell nanoparticle carrier and drug release response10.1016/j.actbio.2007.05.011 ↗
37. Polysaccharide-decorated nanoparticles10.1016/j.ejpb.2004.02.016 ↗
38. Roberts · 1992
39. Evaluation of an improved acid hydrolysis–HPLC assay for the acetyl content in chitin and chitosan10.1002/jbm.b.30353 ↗
40. Muzzarelli · 1973
41. Folate receptor-mediated drug targeting: from therapeutics to diagnostics10.1002/jps.20457 ↗
42. Core–shell magnetite nanoparticles surface encapsulated with smart stimuli-responsive polymer: synthesis, characterization and LCST of viable drug-targeting delivery system10.1021/la0636199 ↗
43. Berry · 1962
44. On the suitability of nanocrystalline ferrites as a magnetic carrier for drug delivery: functionalization, conjugation, and drug release behavior10.1016/j.actbio.2006.10.006 ↗
45. Preparation and characterization of (3-aminopropyl) triethoxysilane-coated magnetite nanoparticles10.1016/j.jmmm.2004.01.094 ↗
46. Preparation and characterization of magnetite nanoparticles coated by amino silane10.1016/S0927-7757(02)00305-9 ↗
47. Magnetic behavior of nickel ferrite–polyethylene nanocomposites synthesized by mechanical milling process10.1016/j.mseb.2004.03.002 ↗
48. Surface effects on the magnetic behavior of nanocrystalline nickel ferrites and nickel ferrite-polymer nanocomposites10.1016/j.mseb.2004.08.010 ↗
49. Water-soluble polymers with tunable temperature sensitivity: solution behavior10.1002/polb.10284 ↗
50. SMA–doxorubicin, a new polymeric micellar drug for effective targeting to solid tumors10.1016/j.jconrel.2004.03.027 ↗
51. A new approach to the in vivo and in vitro investigation of drug release from locoregionally delivered microspheres10.1016/j.jconrel.2004.08.004 ↗
52. Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)/poly(e-caprolactone) (PCL) amphiphilic block copolymeric nanospheres. Thermo-responsive drug release behaviors10.1016/S0168-3659(99)00207-2 ↗